Sort
51,593 grants matching “hepatitis”
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
$690,058Elizabeth Jane Parks · University Of Missouri-Columbia · R01 · FY2021 · DK
Targeting extracellular vesicles in neuroblastoma
$690,013Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · CA
Integrated approaches to close the loop in type 1 diabetes
$689,948Yogish C. Kudva · Mayo Clinic Rochester · R01 · FY2010 · DK
Mechanisms in Perinatal Carcinogenesis
$689,893Lucy M Anderson · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Risk Stratification for and Early Detection of Liver Cancer
$689,861Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2020 · CA
Impact of HCV Therapy on CNS Outcomes
$689,684Ajay R Bharti · University Of California, San Diego · R01 · FY2015 · DA
Core--Special Animal
$689,667Sanjeev Gupta · Albert Einstein College Of Medicine · P30 · FY2008 · DK
Small molecule biased agonists of the NPS receptor
$689,627Scott P Runyon · Research Triangle Institute · R56 · FY2017 · MH
Impact of Drug Policy Reform on the HIV Risk Environment among IDUs in Tijuana
$689,624Steffanie A Strathdee · University Of California, San Diego · R37 · FY2019 · DA
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease
$689,607Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · DK
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease
$689,607Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · DK
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease
$689,607Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · DK
Pharmacologic targeting of the UPR in obesity-linked liver dysfunction
$689,587Enrique Saez · Scripps Research Institute, The · R01 · FY2025 · DK
Homeostatic Responses to Amino Acid Insufficiency
$689,525Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2021 · DK
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
$689,516Elizabeth Jane Parks · University Of Missouri-Columbia · R01 · FY2019 · DK
Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
$689,457Martin F Shapiro · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK
DAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service Programs
$689,437Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · DA
Studies of Rare Cancers
$689,433Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Increasing Involvement of MSM in the Continuum of Care in Kazakhstan
$689,338Elwin Wu · Columbia Univ New York Morningside · R01 · FY2017 · DA
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$689,310Marc R Montminy · Salk Institute For Biological Studies · R01 · FY2009 · DK
Pharmacy Referral Intervention: IDU Access to Services
$689,300Crystal M Fuller · New York Academy Of Medicine · R01 · FY2008 · DA
Mechanistic Pathways of Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females at Risk of Iron Deficiency Anemia
$689,134Mary Dawn Koenig · University Of Illinois At Chicago · R01 · FY2025 · HD
Genetic Epidemiology of Complex Traits
$689,122Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2018 · HG
HCV Genomic Variability in HIV Infected Hemophiliacs
$689,116University Of Cincinnati · R01 · FY2002 · AI
Therapeutic Strategies for the Management of HCV/HIV co- infection
$689,091Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI